Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience.
Saved in:
| Title: | Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience. |
|---|---|
| Authors: | Sandeep KS; Department of Medical Oncology, Rajiv Gandhi Superspeciality Hospital (OPEC), Raichur, Karnataka, India.; Consultant Medical Oncologist, Nandadeepa Cancer Clinic, Raichur, Karnataka, India., Appachu S; Department of Medical Oncology, Sri Shankara Cancer Hospital and Research Centre, Bengaluru, Karnataka, India., Diwaker RB; Department of Medical Oncology, Sri Shankara Cancer Hospital and Research Centre, Bengaluru, Karnataka, India., Vivek S; Department of Medical Oncology, Sri Shankara Cancer Hospital and Research Centre, Bengaluru, Karnataka, India., Simha VVS; Department of Medical Oncology, Sri Shankara Cancer Hospital and Research Centre, Bengaluru, Karnataka, India. |
| Source: | Indian journal of cancer [Indian J Cancer] 2025 Oct 01; Vol. 62 (4), pp. 541-547. Date of Electronic Publication: 2026 Mar 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Medknow Publications Country of Publication: India NLM ID: 0112040 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-4774 (Electronic) Linking ISSN: 0019509X NLM ISO Abbreviation: Indian J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1998-4774 |
|---|---|
| DOI: | 10.4103/ijc.ijc_643_23 |
